Hematology & Oncology
John Climaco, CEO of CNS Pharmaceuticals, Discusses New Treatment for Glioblastoma
| Categories: hematology-oncology, newsletter
John Climaco, Chief Executive Officer of CNS Pharmaceuticals, recently sat down with DocWire News to discuss Berubicin, a drug used to treat patients with glioblastoma […]